Updated CPG: Sodium valproate poisoning
Sodium valproate poisoning was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Sodium valproate poisoning was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Kawasaki Disease was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was discussed by the CPG committee on 1 October 2020.
Febrile seizure was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Oral hypoglycaemic poisoning is a new CPG that was endorsed for Victorian use on 18 February 2021 and requires consideration by interstate reviewers before endorsement by PIC.
Acute otitis media was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Hypernatraemia was an existing Victorian CPG and was endorsed by PIC on 26 November 2020. The revision was discussed by the CPG committee on 19 August 2020.
Jaundice in early infancy was an existing RCH CPG and was endorsed by PIC on 26 November 2020. The revision was discussed by the CPG committee on 3 September 2020.
February 2021 – The Following CPGs have been endorsed by the Paediatric Improvement Collaborative …..
CPGs published in February 2021 plus details of topics considered by the CPG Committee
CPGs published in December 2020 and January 2021 plus details of topics considered by the CPG Committee